Table 2:
Frequency of product type under evaluation & area of use according to the usage goal
Variables | Diagnosis | Education | Follow-up | monitoring | prevention | Rehabilitation | Screening | Treatment | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||
N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | ||
Type of product | App | 6 | 55 | 28 | 62 | 4 | 57 | 4 | 36 | 2 | 100.00 | 2 | 40.00 | 5 | 26 | 16 | 22 | 67 | 39 |
PC-based system | 5 | 45 | 17 | 38 | 3 | 43 | 7 | 64 | 0 | 0.00 | 3 | 43 | 14 | 77 | 58 | 78 | 107 | 61 | |
CPOE | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 2 | 3 | 2 | 1 | |
DSS | 6 | 55 | 1 | 2 | 1 | 14 | 2 | 18 | 0 | 0.00 | 0 | 0.00 | 5 | 26 | 11 | 15 | 26 | 15 | |
E-H-R | 0 | 0.00 | 1 | 2 | 0 | 0.00 | 1 | 9 | 0 | 0.00 | 0 | 0.00 | 1 | 5 | 9 | 12 | 12 | 7 | |
HIS | 0 | 0.00 | 2 | 4 | 1 | 14 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 20 | 27 | 23 | 13 | |
Registry | 1 | 9 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 1 | 5 | 1 | 1 | 3 | 2 | |
Area of use | Telemedicine | 4 | 36 | 41 | 91 | 5 | 71 | 8 | 73 | 2 | 100.00 | 5 | 100.00 | 12 | 63 | 29 | 39 | 106 | 61 |
VR | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 2 | 3 | 2 | 1 | |
Total | 11 | 6 | 45 | 26 | 7 | 4 | 11 | 6 | 2 | 1 | 5 | 3 | 19 | 11 | 74 | 43 | 174 | 100 |